Clinical Trial

A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022

Name: A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022 — clinical trial record (NCT07317713)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Carcinoid tumors are rare neuroendocrine tumors with slowly progressive course with the sites are small intestine accounting for 45%, rectum (20%), appendix (17%), colon (11%), and stomach (7%). This study focus on the mortality risk analysis for GI carcinoids due to data insufficiency in the literature.

Trial Details

NCT Number	NCT07317713
Lead Sponsor	Suez Canal University
Conditions	Carcinoid Tumor
Enrollment	93,481 participants
Start Date	2000-12-01
Primary Completion	2022-12-30 (estimated)
Study Completion	2022-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-05